GlaxoSmithKline Pharma reports 61% fall in Q3 net profit

12 Feb 2015 Evaluate

GlaxoSmithKline Pharmaceuticals has reported results for third quarter ended December 31, 2014.

The company has registered a fall of 61.24% in its net profit from ordinary activities after tax at Rs 45.30 crore for the quarter under review as compared to Rs 116.88 crore for the same quarter in the previous year. Total income of the company increased marginally by 0.52% at Rs 688.63 crore for Q3FY15 as compared Rs 685.04 crore for the corresponding quarter previous year.

GlaxoSmithKline Pharmaceuticals is one oldest pharmaceutical company in India. Internationally it has created many brands such as Ribena, Horlicks, Lucozade, Aquafresh, Sensodyne, Panadol, Tums and Zovirax, among others. It employs 5,000 people and has turnover of more than $1 billion in India.

 

Glaxosmithkline Phar Share Price

2543.10 33.80 (1.35%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×